Bayer Competitors and Similar CompaniesClear all
Bayer's competitors and similar companies include Novartis, GSK and Johnson & Johnson.
 Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  GSK GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. |  Johnson & Johnson Johnson & Johnson (J&J) is a company that engages in the research and development, manufacture, and sale of a range of products in the healthcare field. | ||
Founding Date | Founding Date 1863 | Founding Date 1996 | Founding Date 2000 | Founding Date 1886 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations London, GB HQ Boumerdes, DZ Buenos Aires, AR Abbotsford, AU Wien, AT Wavre, BE Rio De Janeiro, BR see more | Locations New Brunswick, US HQ Buenos Aires, AR Sydney, AU Vienna, AT Minsk, BY Beerse, BE Sofia, BG see more | |
Employees | Employees 88,5021% decrease | Employees 75,883 | Employees 68,629 | Employees 138,1005% increase |
Valuation ($) | Valuation ($) 27.1 b | Valuation ($) N/A | Valuation ($) 862.5 m | Valuation ($) 396.3 b |
Financial | ||||
Revenue (est.) | Revenue (est.) €45.6b (FY, 2025) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) £32.7b (FY, 2025) | Revenue (est.) $94.2b (FY, 2025) |
Cost of goods | Cost of goods €14b (FY, 2025) | Cost of goods $8.4b (FY, 2025) | Cost of goods £5.6b (FY, 2025) | Cost of goods $30.3b (FY, 2025) |
Gross profit | Gross profit €32.5b (FY, 2025) | Gross profit $49.8b (FY, 2025) | Gross profit £28.5b (FY, 2025) | Gross profit $63.9b (FY, 2025) |
Net income | Net income (€3.6b) (FY, 2025) | Net income $14b (FY, 2025) | Net income £6.3b (FY, 2025) | Net income $26.8b (FY, 2025) |
Operating ⚠ | ||||
Countries | Countries 83 (FY, 2021) | Countries N/A | Countries 92 (FY, 2021) | Countries N/A |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products 44 (FY, 2022) | Phase III Trials Products 11 (FY, 2021) | Phase III Trials Products N/A |
Suppliers | Suppliers 93.8 k (FY, 2021) | Suppliers N/A | Suppliers 37.5 k (FY, 2021) | Suppliers N/A |
Funding | ||||
Total funding raised | Total funding raised $ 3.5b | Total funding raised $ 6.5m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Novartis
HQ
Basel, CH
Employees
75,883
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View companyGSK
HQ
London, GB
Employees
68,629
GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products.
View companyJohnson & Johnson
HQ
New Brunswick, US
Employees
138,100↑ 5% increase
Johnson & Johnson (J&J) is a company that engages in the research and development, manufacture, and sale of a range of products in the healthcare field.
View company